DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 134 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $382,000 | +445.7% | 106,738 | +508.6% | 0.02% | +375.0% |
| Q2 2019 | $70,000 | -93.3% | 17,538 | -87.7% | 0.00% | -93.5% |
| Q1 2019 | $1,040,000 | +98.1% | 142,338 | +147.9% | 0.06% | +82.4% |
| Q4 2018 | $525,000 | -68.8% | 57,410 | -57.7% | 0.03% | -55.8% |
| Q3 2018 | $1,684,000 | +41.2% | 135,810 | +73.5% | 0.08% | +57.1% |
| Q2 2018 | $1,193,000 | -78.7% | 78,262 | -73.9% | 0.05% | -80.2% |
| Q4 2017 | $5,608,000 | +10.0% | 299,910 | +26.5% | 0.25% | -4.6% |
| Q3 2017 | $5,097,000 | +60.7% | 237,102 | +83.4% | 0.26% | +122.2% |
| Q3 2015 | $3,172,000 | +159.2% | 129,284 | +147.2% | 0.12% | +185.4% |
| Q2 2015 | $1,224,000 | +115.5% | 52,291 | +106.4% | 0.04% | +105.0% |
| Q1 2015 | $568,000 | +64.2% | 25,338 | +23.2% | 0.02% | +53.8% |
| Q4 2014 | $346,000 | – | 20,572 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |